On Tuesday, September 13, 2022, the Korean company C&H, which is engaged in cannabis and CBD research and product development, announced the release of a new pink device for their non-nicotine and non-tar CBD e-cigarette, called "RICHILL".
RICHILL is a CBD vape that is free of nicotine and tar, and is currently being studied worldwide.
Disclaimer: 1. The content of this article is compiled from third-party information and is intended for industry communication and learning purposes only. 2. The views expressed in this article do not represent the opinions of 2FIRSTS and 2FIRSTS is unable to confirm the truthfulness and accuracy of the content. The compilation of this article is for industry communication and research purposes only. 3. Due to limitations in translation ability, the compiled article may not fully convey the original message. Please refer to the original text for accuracy. 4. In all domestic, Hong Kong, Macau, Taiwan, and foreign statements and positions, 2FIRSTS is fully aligned with the Chinese government. 5. The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to delete the content.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
